For press inquiries click here to contact us.
GenomeWeb
10X Genomics Moves Out Of Shadows With Planned Launch Of Synthetic Long-Read Technology In 2015
Fortune
Term Sheet – Tuesday, January 13: 10X Genomics
Forbes
Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing
The Business Journals
Intarcia Announces $1B License Deal For Diabetes Pump
BioWorld
Intarcia, Servier Sign Potential $1B Deal For Exenatide Implant In Type 2 Diabetes
The Wall Street Journal
New Implantable Pump Could Cut Diabetes Treatments
Xconomy
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More
The Boston Globe
Intarcia Raises $200m To Advance Its Diabetes Drug
FierceBiotech
Investors Pump $200M Into Intarcia’s PhIII For Once-Yearly Diabetes Therapy
Please see important disclaimers in the Terms section.
